Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Operating Leases (2023 - 2026)

Adagio Medical Holdings (ADGM) reported Operating Leases of $992000.0 for Q1 2026, up 48.5% year-over-year from $668000.0 in Q1 2025, and up 76.2% on a QoQ basis from $563000.0 in Q4 2025.

Adagio Medical Holdings (ADGM) has 4 years of Operating Leases data on file, last reported at $992000.0 in Q1 2026.

  • Quarterly Operating Leases rose 48.5% year-over-year to $992000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $992000.0 (up 48.5% YoY) and the FY2025 annual result came in at $563000.0, up 1123.91% from the prior year.
  • Operating Leases grew to $992000.0 in Q1 2026 per ADGM's latest filing, from $563000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $992000.0 in Q1 2026 and bottomed at $46000.0 in Q4 2024.
  • The 4-year median for Operating Leases is $579500.0 (2025), against an average of $453875.0.
  • The widest annual swing landed in 2024, when Operating Leases declined 11.54%; it then surged 1123.91% in 2025.
  • Tracing ADGM's Operating Leases over 4 years: stood at $52000.0 in 2023, then slipped by 11.54% to $46000.0 in 2024, then surged by 1123.91% to $563000.0 in 2025, then jumped by 76.2% to $992000.0 in 2026.
  • Per Business Quant, the three latest ADGM Operating Leases figures stand at $992000.0 (Q1 2026), $563000.0 (Q4 2025), and $596000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Adagio Medical Holdings 16.86 Mn 3.95 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 992,000.00
Dec 31, 2025 563,000.00
Sep 30, 2025 596,000.00
Jun 30, 2025 629,000.00
Mar 31, 2025 668,000.00
Dec 31, 2024 46,000.00
Sep 30, 2024 85,000.00
Dec 31, 2023 52,000.00